Literature DB >> 30658723

Alcohol-related liver disease: Time for action.

Ramon Bataller1, Gavin E Arteel2, Christophe Moreno3, Vijay Shah4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30658723      PMCID： PMC6416779          DOI： 10.1016/j.jhep.2018.12.007

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  20 in total

1.  Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide.

Authors:  Eva Stein; Monica Cruz-Lemini; Jose Altamirano; Nambi Ndugga; David Couper; Juan G Abraldes; Ramon Bataller
Journal:  J Hepatol       Date:  2016-07-05       Impact factor: 25.083

Review 2.  Inflammatory pathways in alcoholic steatohepatitis.

Authors:  Bin Gao; Maleeha F Ahmad; Laura E Nagy; Hidekazu Tsukamoto
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 3.  Liver transplantation for alcoholic hepatitis.

Authors:  Gene Y Im; Andrew M Cameron; Michael R Lucey
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 4.  Treatment of alcohol use disorders in patients with alcoholic liver disease.

Authors:  Giovanni Addolorato; Antonio Mirijello; Pablo Barrio; Antoni Gual
Journal:  J Hepatol       Date:  2016-05-04       Impact factor: 25.083

Review 5.  Therapeutic Strategies for the Treatment of Alcoholic Hepatitis.

Authors:  Ashwani K Singal; Vijay H Shah
Journal:  Semin Liver Dis       Date:  2016-02-12       Impact factor: 6.115

Review 6.  Fibrosis and alcohol-related liver disease.

Authors:  Carolin Lackner; Dina Tiniakos
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 7.  Non-invasive diagnosis and biomarkers in alcohol-related liver disease.

Authors:  Christophe Moreno; Sebastian Mueller; Gyongyi Szabo
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 8.  Treating alcohol-related liver disease from a public health perspective.

Authors:  Theresa Hydes; William Gilmore; Nick Sheron; Ian Gilmore
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 9.  Alcoholic liver disease.

Authors:  Helmut K Seitz; Ramon Bataller; Helena Cortez-Pinto; Bin Gao; Antoni Gual; Carolin Lackner; Philippe Mathurin; Sebastian Mueller; Gyongyi Szabo; Hidekazu Tsukamoto
Journal:  Nat Rev Dis Primers       Date:  2018-08-16       Impact factor: 52.329

Review 10.  Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis.

Authors:  Astrid Marot; Margaux Dubois; Eric Trépo; Christophe Moreno; Pierre Deltenre
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240
View more
  9 in total

Review 1.  Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder.

Authors:  Falk W Lohoff
Journal:  Front Psychiatry       Date:  2022-06-09       Impact factor: 5.435

2.  Coexistent Alcohol-Related Liver Disease and Alcohol-Related Pancreatitis: Analysis of a Large Health Care System Cohort.

Authors:  Gavin E Arteel; Ajay Singhvi; Robert Feldman; Andrew D Althouse; Ramon Bataller; Melissa Saul; Dhiraj Yadav
Journal:  Dig Dis Sci       Date:  2021-05-07       Impact factor: 3.487

Review 3.  Liver specific, systemic and genetic contributors to alcohol-related liver disease progression.

Authors:  Bernd Schnabl; Gavin E Arteel; Felix Stickel; Jan Hengstler; Nachiket Vartak; Ahmed Ghallab; Steven Dooley; Yujia Li; Robert F Schwabe
Journal:  Z Gastroenterol       Date:  2022-01-18       Impact factor: 1.769

Review 4.  Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.

Authors:  Khushboo S Gala; Vatsalya Vatsalya
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

5.  Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort study.

Authors:  Ha Il Kim; Seo Young Park; Hyun Phil Shin
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

Review 6.  Role of cell-free network communication in alcohol-associated disorders and liver metastasis.

Authors:  Murali R Kuracha; Peter Thomas; Martin Tobi; Benita L McVicker
Journal:  World J Gastroenterol       Date:  2021-11-07       Impact factor: 5.742

7.  Analysis of Clinical Characteristics of Hepatitis B and Alcohol-Related Liver Cancer.

Authors:  Yuefei Pan; Guiliang Han
Journal:  Comput Math Methods Med       Date:  2021-11-18       Impact factor: 2.238

8.  Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the Kuopio Ischaemic Heart Disease Risk Factor Study Cohort.

Authors:  Olubunmi O Olubamwo; Jyrki K Virtanen; Jussi Pihlajamaki; Pekka Mantyselka; Tomi-Pekka Tuomainen
Journal:  BMJ Open       Date:  2019-09-05       Impact factor: 2.692

9.  PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease.

Authors:  Ji Soo Lee; Partha Mukhopadhyay; Csaba Matyas; Eszter Trojnar; Janos Paloczi; Yuan Ru Yang; Brandon A Blank; Cody Savage; Alexander V Sorokin; Nehal N Mehta; Janaina C M Vendruscolo; George F Koob; Leandro F Vendruscolo; Pal Pacher; Falk W Lohoff
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.